KCNQ1DN suppresses RCC cell proliferation and cell cycle progression by inhibiting the transcription and reducing the expression of c-Myc, which up-regulates cyclin D1 and down-regulates p27 [59]. Here, MYC is linked to renal cell carcinoma.